# mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

# Moderna和默克称mRNA癌症疫苗在黑色素瘤三期试验中取得成功

作者: Beth Mole | 分类: Health, cancer, cancer vaccine, merck | 原文: arstechnica.com

时间: Wed, 19 Aug 2026 16:53:56 +0000

Pharmaceutical partners Moderna and Merck announced on Wednesday that their novel mRNA-based vaccine—individually tailored to target a patient's unique cancer mutations—was effective in a late-stage clinical trial of patients with melanoma, one of the deadliest forms of skin cancer.

⋯ 继续阅读请开通会员 ⋯